Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma

This study is ongoing, but not recruiting participants.

Study NCT00634205 Information provided by European Lung Cancer Working Party

First Received: March 5, 2008 Last Updated: April 3, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)

No publications provided by European Lung Cancer Working Party

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, Willems L, Sculier JP; European Lung Cancer Working Party (ELCWP). Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study. Eur Respir J. 2011 Jan;37(1):129-35. Epub 2010 Jun 7.